COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 224: Articles 2231-2240  | Next

SARS-CoV-2 infection unevenly impacts metabolism in the coronal periphery of the lungs
Laro, J. A., Xue, B., Zheng, J., Ness, M., Perlman, S., McCall, L.-I.
10.1101/2024.05.22.595414 — Posted: 2024-05-23
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection
Lieber, C. M., Kang, H.-J., Sobolik, E. B., Sticher, Z. M., Ngo, V. L., Gewirtz, A. T., Kolykhalov, A. A., Natchus, M. G., Greninger, A. L., Suthar, M. S., Plemper, R. K.
10.1101/2024.05.23.595478 — Posted: 2024-05-23
Rapid SARS-CoV-2 Detection Using High-Sensitivity Thickness Shear Mode Sensors
Saleh, S., Alkalamouni, H., Antar, K., Rahme, J., Muthuswamy, J., Karam, P., Zaraket, H., Khraiche, M.
10.1101/2024.05.22.594713 — Posted: 2024-05-23
Subclinical SARS-CoV-2 Infections and Endemic Human Coronavirus Immunity Shape SARS-CoV-2 Saliva Antibody Responses
Conner, T. L., Goguet, E., Haines-Hull, H., Segard, A., Darcey, E., Kobi, P., Balogun, B., Olsen, C., Esposito, D., Jones, M., Burgess, T., O'Connell, R. J., Broder, C. C., Saunders, D., Pollett, S., Laing, E. D., Mitre, E.
10.1101/2024.05.22.24307751 — Posted: 2024-05-22
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: population-based, nested case-control study
Peter, R. S., Nieters, A., Göpel, S., Merle, U., Steinacker, J. M., Deibert, P., Friedmann-Bette, B., Niess, A., Müller, B., Schilling, C., Erz, G., Giesen, R., Götz, V., Keller, K., Maier, P., Matits, L., Parthe, S., Rehm, M., Schellenberg, J., Schempf, U., Zhu, M., Kräusslich, H.-G., Rothenbacher, D., Kern, W. V.
10.1101/2024.05.22.24307659 — Posted: 2024-05-22
Pediatric Gastrointestinal Outcomes During the Post-Acute Phase of COVID-19
Zhang, D., Stein, R., Lu, Y., Zhou, T., Lei, Y., Li, L., Chen, J., Arnold, J., Becich, M., Chrischilles, E. A., Chuang, C. H., Christakis, D. A., Fort, D., Geary, C. R., Hornig, M., Kaushal, R., Liebovitz, D. M., Mosa, A. S. M., Morizono, H., Mirhaji, P., Dotson, J. L., Pulgarin, C., Sills, M. R., Suresh, S., Williams, D. A., Baldassano, R. N., Forrest, C. B., Chen, Y., RECOVER Initiative
10.1101/2024.05.21.24307699 — Posted: 2024-05-22
MicroRNA-374b regulates SARS-CoV-2 viral protein mediated endothelial to mesenchymal transition by targeting c-FLIP
Rajan, G. R., Poyyakkara, A., Ramachandran, V., Kunhikrishnan, A., Sameer Kumar, V. B.
10.1101/2024.05.22.595176 — Posted: 2024-05-22
An anti-SARS-CoV-2 formula consisting volatile oil from TCM through inhibiting multiple targets in cultured cells
Zhang, H., Guo, W., Shen, J., Song, X., Zhang, B.
10.1101/2024.05.22.595089 — Posted: 2024-05-22
SARS-CoV-2 sequencing artifacts associated with targeted PCR enrichment and read mapping
Ellegaard, K. M., Gunalan, V., Sieber, R., Baig, S. J., Larsen, N. B., Bennedbaek, M., Bybjerg-Grauholm, J., Escobar-Herrera, L. A., Hansen, T. N. G., Thorsen, T. H., Krusager, A., Aasbjerg, G. N., Al-Tamimi, N. S., Westergaard, C., Svarrer, C. W., Rasmussen, M., Stegger, M.
10.1101/2024.05.22.595297 — Posted: 2024-05-22
Exploring the ability of the MD+FoldX method to predict SARS-CoV-2 antibody escape mutations using large-scale data
Chi, L. A., Barnes, J. E., Suresh Patel, J., Ytreberg, F. M.
10.1101/2024.05.22.595230 — Posted: 2024-05-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).